Navigation Links
Experimental Weight-Loss Drug Seems to Work: Study
Date:4/11/2011

, constipation (17 percent), insomnia, dizziness and distorted taste (10 percent each).

Paresthesia is a common side effect of phentermine, Gadde noted, while the other side effects are most likely associated with topiramate.

An increased risk of depression and anxiety was also noted in those taking the drugs, seeming to increase as the dosage given rose. About twice the number of people in the high-dose drug groups dropped out of the trial compared to people receiving counseling alone, the researchers noted.

"If you see side effects like depression and anxiety, you need to be more careful," Gadde said. "You don't give these drugs to someone who is clinically depressed," he added.

According to Gadde, there were no birth defects among any of the babies born to the 34 women who became pregnant while taking Qnexa in this trial.

Ashley Buford, a spokeswoman for Vivus, said the company is hoping to resubmit its application for approval of Qnexa to the FDA by the end of the year.

Commenting on the study, obesity expert Dr. David L. Katz, director of the Prevention Research Center at Yale University School of Medicine, said that "this study shows what we had cause to believe before: that Qnexa facilitates weight loss beyond office-based counseling alone, as long as people are taking the drug."

However, the weight loss may be unlikely to persist if use of the drug stops, he said.

"In addition, we don't yet know if Qnexa is safe for long-term, or even lifelong use, and thus cannot yet say whether it is safe and useful for long-term weight control," Katz said. "Other drugs that have facilitated weight loss in the short term have failed to translate to safe and effective long-term use. This is the bar a truly useful weight-loss drug will need to clear," he said.

More information

For more on obesity, visit the U.S. National Library of Me
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Experimental drug achieves unprecedented weight loss
2. Science at a glance: Symposia, research and special events at Experimental Biology 2011
3. A new experimental diagnostic test able to quickly distinguish infection from tuberculosis disease
4. Extra Tests Not a Deterrent to Experimental Cancer Therapy
5. 2 Experimental Drugs Show Promise for Rare Pancreatic Cancer
6. Experimental approach may improve healing of diabetic wounds and bed sores
7. Study raises safety concerns about experimental cancer approach
8. First liver transplant patients receive experimental drug to prevent hepatitis C infection
9. Experimental Drug Helps Fight Aggressive Breast Cancer: Report
10. Experimental drug more potent, longer lasting than morphine
11. Experimental vaccine sets sights on lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Weight-Loss Drug Seems to Work: Study
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... JANEIRO, Brazil, March 11 Amilpar,(BOVESPA: AMIL3, Bloomberg: ... organization in Brazil, announced today its consolidated,results for ... 2007. The Company,s,operational and financial information is presented ... accordance with Brazilian Corporate Law and the,Accounts Chart ...
... Wilkins Speaks on Behalf of People with ... Diabetes During Congressional Briefing, WASHINGTON, March ... Members of Congress to support,a bill that will develop a ... Wilkins was joined today at a briefing on Capitol,Hill by ...
... cells in the human brain are not nerve cells, but supporting ... and play an important role in the wound reaction that occurs ... in the brains of mice and men originate from, and which ... group of Prof. Dr. Magdalena Gtz is able to show that ...
... Inc.,(NYSE: RBN ) announced today that it will ... the period ended February 29, 2008, after,market close on ... conference,call will be held at 2:00 p.m., EDT on ... Chief Executive Officer, and Christopher M. Hix,Vice President and ...
... COLUMBUS, Ohio, March 11 Mettler-Toledo,International Inc. (NYSE: ... the Lehman Brothers Global Healthcare Conference in Miami,on Tuesday, ... hear a live,webcast of the presentation, visit the investor ... . A replay of the webcast will be,available for ...
... (March 11, 2008) -- A test that profiles molecular biomarkers ... Parkinson,s disease, new research shows. , The screen relies on ... alterations form a unique pattern in people with Parkinson,s disease, ... Cornell Medical College in New York City. , They published ...
Cached Medicine News:Health News:Amilpar Revenues Increase by 32% and EBITDA Doubles in 2007 2Health News:Diabetes Advocates Urge Members of Congress to Support Creation of National Diabetes Coordinator 2Health News:Diabetes Advocates Urge Members of Congress to Support Creation of National Diabetes Coordinator 3Health News:First early-detection blood test for Parkinson's shows promise 2Health News:First early-detection blood test for Parkinson's shows promise 3
(Date:1/14/2014)... 14, 2014   NuAire , a manufacturer of ergonomically ... agreement with Hitachi Koki of Japan ... centrifuges in North America . NuAire will ... United States and Canada ... options and accessories, training, pricing, as well as after sale ...
(Date:1/14/2014)... N.Y. , Jan. 14, 2014   Oligomerix, ... development of disease modifying therapeutics for Alzheimer,s disease ... relocation of its corporate headquarters to ... 2014 and expanded lease agreement for additional laboratory ... Oligomerix, which is focused on the development of ...
(Date:1/14/2014)... Jan. 14, 2014   Evidera , a ... industry, announced that the Center for Drug Evaluation ... has released its first draft qualification guidance document ... development: Qualification of Exacerbations of Chronic Pulmonary ... Acute Bacterial Exacerbation of Chronic Bronchitis in Patients ...
Breaking Medicine Technology:NuAire announces sales and service of Hitachi Koki centrifuges in North America 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
Jaffe tying forceps is very delicate with smooth jaws, straight, 6 mm long platform. For 8-0 to 11-0 sutures....
Straight heavy shafts with 7 mm tying surface. Wide serrated handle, polished finish. Overall length 4.2 inches....
Tying forceps with 6.5 mm tying platform. Round handle with flats provide flexibility of round handle with the stability of a flat handle. Straight shafts. Overall length 3.9 inches....
Curved shafts with 4 mm tying platform. Serrated handle with dull finish. Manufactured in titanium. Overall length 3.3 inches....
Medicine Products: